BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 10649264)

  • 1. Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas.
    Bouffet E; Raquin M; Doz F; Gentet JC; Rodary C; Demeocq F; Chastagner P; Lutz P; Hartmann O; Kalifa C
    Cancer; 2000 Feb; 88(3):685-92. PubMed ID: 10649264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor-risk Ewing-Sarcoma-Family tumors.
    Hawkins D; Barnett T; Bensinger W; Gooley T; Sanders J
    Med Pediatr Oncol; 2000 May; 34(5):328-37. PubMed ID: 10797354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High-dose chemotherapy in relapse of medulloblastoma in young children].
    Dupuis-Girod S; Hartmann O; Benhamou E; Doz F; Mechinaud F; Bouffet E; Coze C; Kalifa C
    Bull Cancer; 1997 Mar; 84(3):264-72. PubMed ID: 9207872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study.
    Kalifa C; Hartmann O; Demeocq F; Vassal G; Couanet D; Terrier-Lacombe MJ; Valteau D; Brugieres L; Lemerle J
    Bone Marrow Transplant; 1992 Apr; 9(4):227-33. PubMed ID: 1534708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy.
    Ridola V; Grill J; Doz F; Gentet JC; Frappaz D; Raquin MA; Habrand JL; Sainte-Rose C; Valteau-Couanet D; Kalifa C
    Cancer; 2007 Jul; 110(1):156-63. PubMed ID: 17541945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group.
    Dunkel IJ; Garvin JH; Goldman S; Ettinger LJ; Kaplan AM; Cairo M; Li H; Boyett JM; Finlay JL
    J Neurooncol; 1998 Mar; 37(1):67-73. PubMed ID: 9525840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas.
    Heideman RL; Douglass EC; Krance RA; Fontanesi J; Langston JA; Sanford RA; Kovnar EH; Ochs J; Kuttesch J; Jenkins JJ
    J Clin Oncol; 1993 Aug; 11(8):1458-65. PubMed ID: 8336185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors.
    Modak S; Gardner S; Dunkel IJ; Balmaceda C; Rosenblum MK; Miller DC; Halpern S; Finlay JL
    J Clin Oncol; 2004 May; 22(10):1934-43. PubMed ID: 15143087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.
    Finlay JL; Goldman S; Wong MC; Cairo M; Garvin J; August C; Cohen BH; Stanley P; Zimmerman RA; Bostrom B; Geyer JR; Harris RE; Sanders J; Yates AJ; Boyett JM; Packer RJ
    J Clin Oncol; 1996 Sep; 14(9):2495-503. PubMed ID: 8823328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nimotuzumab-containing regimen for pediatric diffuse intrinsic pontine gliomas: a retrospective multicenter study and review of the literature.
    Kebudi R; Cakir FB; Bay SB; Gorgun O; Altınok P; Iribas A; Agaoglu FY; Darendeliler E
    Childs Nerv Syst; 2019 Jan; 35(1):83-89. PubMed ID: 30417211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study.
    Grill J; Kalifa C; Doz F; Schoepfer C; Sainte-Rose C; Couanet D; Terrier-Lacombe MJ; Valteau-Couanet D; Hartmann O
    Pediatr Neurosurg; 1996 Jul; 25(1):7-12. PubMed ID: 9055328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.
    DeFilipp Z; Li S; El-Jawahri A; Armand P; Nayak L; Wang N; Batchelor TT; Chen YB
    Cancer; 2017 Aug; 123(16):3073-3079. PubMed ID: 28369839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain magnetic resonance imaging after high-dose chemotherapy and radiotherapy for childhood brain tumors.
    Spreafico F; Gandola L; Marchianò A; Simonetti F; Poggi G; Adduci A; Clerici CA; Luksch R; Biassoni V; Meazza C; Catania S; Terenziani M; Musumeci R; Fossati-Bellani F; Massimino M
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1011-9. PubMed ID: 17904307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the "head-start" I and II clinical trials.
    Osorio DS; Patel N; Ji L; Sposto R; Stanek J; Gardner SL; Allen JC; Cornelius A; McCowage GB; Termuhlen A; Dunkel IJ; Comito M; Garvin J; Finlay JL
    J Neurooncol; 2018 Dec; 140(3):717-725. PubMed ID: 30392092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-radiation chemotherapy improves survival in pediatric diffuse intrinsic pontine gliomas.
    Gokce-Samar Z; Beuriat PA; Faure-Conter C; Carrie C; Chabaud S; Claude L; Di Rocco F; Mottolese C; Szathmari A; Chabert C; Frappaz D
    Childs Nerv Syst; 2016 Aug; 32(8):1415-23. PubMed ID: 27379495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose busulfan-thiotepa with autologous stem cell transplantation followed by posterior fossa irradiation in young children with classical or incompletely resected medulloblastoma.
    Bergthold G; El Kababri M; Varlet P; Dhermain F; Sainte-Rose C; Raquin MA; Kieffer V; Goma G; Grill J; Valteau-Couanet D; Dufour C
    Pediatr Blood Cancer; 2014 May; 61(5):907-12. PubMed ID: 24470384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome.
    Lee JL; Gooley T; Bensinger W; Schiffman K; McDonald GB
    Biol Blood Marrow Transplant; 1999; 5(5):306-15. PubMed ID: 10534061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose chemotherapy with autologous stem cell rescue as first line of treatment in young children with medulloblastoma and supratentorial primitive neuroectodermal tumors.
    Pérez-Martínez A; Quintero V; Vicent MG; Sevilla J; Díaz MA; Madero L
    J Neurooncol; 2004; 67(1-2):101-6. PubMed ID: 15072454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of high-dose thiotepa with busulfan, etoposide, and autologous stem cell support in children with disseminated solid tumors.
    Pession A; Prete A; Locatelli F; Bella S; Melchionda F; Garaventa A; Burnelli R; Paolucci G
    Med Pediatr Oncol; 1999 Nov; 33(5):450-4. PubMed ID: 10531568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas.
    Packer RJ; Krailo M; Mehta M; Warren K; Allen J; Jakacki R; Villablanca JG; Chiba A; Reaman G
    Cancer; 2005 Nov; 104(9):1968-74. PubMed ID: 16177987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.